New shortened drug regimens to treat TB patients
A landmark clinical trial has revealed evidence supporting the use of four new and improved regimens able to treat multi-drug resistant tuberculosis also known as rifampicin-resistant tuberculosis (MDR/RR-TB) among children
Read on